VolitionRX Ltd (AMEX: VNRX) Stock Competitors & Peer Comparison

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ABT has a market cap of 201.8B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ABT trades at $116.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ABT's P/E ratio is 22.39. In terms of profitability, VNRX's ROE is +0.77%, compared to ABT's ROE of +0.11%. Regarding short-term risk, VNRX is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ABT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VNRX's ROE is +0.77%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, VNRX is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BSX-PA's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SYK has a market cap of 126.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SYK trades at $329.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SYK's P/E ratio is 24.59. In terms of profitability, VNRX's ROE is +0.77%, compared to SYK's ROE of +0.16%. Regarding short-term risk, VNRX is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SYK's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, MDT has a market cap of 119.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while MDT trades at $93.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas MDT's P/E ratio is 16.88. In terms of profitability, VNRX's ROE is +0.77%, compared to MDT's ROE of +0.10%. Regarding short-term risk, VNRX is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check MDT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BSX has a market cap of 74.9B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BSX trades at $50.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BSX's P/E ratio is 16.25. In terms of profitability, VNRX's ROE is +0.77%, compared to BSX's ROE of +0.15%. Regarding short-term risk, VNRX is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BSX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while EW trades at $89.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas EW's P/E ratio is 33.26. In terms of profitability, VNRX's ROE is +0.77%, compared to EW's ROE of +0.10%. Regarding short-term risk, VNRX is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check EW's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, DXCM has a market cap of 34.8B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while DXCM trades at $92.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas DXCM's P/E ratio is 36.21. In terms of profitability, VNRX's ROE is +0.77%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, VNRX is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check DXCM's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, RMD has a market cap of 33.6B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while RMD trades at $231.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas RMD's P/E ratio is 21.49. In terms of profitability, VNRX's ROE is +0.77%, compared to RMD's ROE of +0.24%. Regarding short-term risk, VNRX is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check RMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PHG has a market cap of 26.8B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PHG trades at $27.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PHG's P/E ratio is 15.67. In terms of profitability, VNRX's ROE is +0.77%, compared to PHG's ROE of +0.10%. Regarding short-term risk, VNRX is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check PHG's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ZBH has a market cap of 19.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ZBH trades at $100.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ZBH's P/E ratio is 11.91. In terms of profitability, VNRX's ROE is +0.77%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, VNRX is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ZBH's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VNRX's ROE is +0.77%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VNRX is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ABMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PEN trades at $325.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PEN's P/E ratio is 84.91. In terms of profitability, VNRX's ROE is +0.77%, compared to PEN's ROE of +0.11%. Regarding short-term risk, VNRX is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check PEN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VNRX's ROE is +0.77%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, VNRX is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SWAV's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SNN has a market cap of 12.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SNN trades at $29.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SNN's P/E ratio is 13.77. In terms of profitability, VNRX's ROE is +0.77%, compared to SNN's ROE of +0.12%. Regarding short-term risk, VNRX is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SNN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, GMED has a market cap of 11.7B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while GMED trades at $86.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas GMED's P/E ratio is 19.58. In terms of profitability, VNRX's ROE is +0.77%, compared to GMED's ROE of +0.12%. Regarding short-term risk, VNRX is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check GMED's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ALGN has a market cap of 11.6B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ALGN trades at $162.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ALGN's P/E ratio is 14.82. In terms of profitability, VNRX's ROE is +0.77%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, VNRX is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ALGN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, GKOS has a market cap of 10.9B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while GKOS trades at $184.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas GKOS's P/E ratio is -214.86. In terms of profitability, VNRX's ROE is +0.77%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, VNRX is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check GKOS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PODD has a market cap of 10.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PODD trades at $148.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PODD's P/E ratio is 25.24. In terms of profitability, VNRX's ROE is +0.77%, compared to PODD's ROE of +0.27%. Regarding short-term risk, VNRX is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check PODD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BIO trades at $380.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BIO's P/E ratio is 40.94. In terms of profitability, VNRX's ROE is +0.77%, compared to BIO's ROE of +0.03%. Regarding short-term risk, VNRX is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BIO's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BIO-B has a market cap of 10B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BIO-B trades at $365.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BIO-B's P/E ratio is -64.28. In terms of profitability, VNRX's ROE is +0.77%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, VNRX is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BIO-B's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while MASI trades at $179.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas MASI's P/E ratio is 44.43. In terms of profitability, VNRX's ROE is +0.77%, compared to MASI's ROE of +0.09%. Regarding short-term risk, VNRX is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check MASI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BRKR has a market cap of 9.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BRKR trades at $59.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BRKR's P/E ratio is 29.93. In terms of profitability, VNRX's ROE is +0.77%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, VNRX is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BRKR's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, HAE has a market cap of 4.9B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while HAE trades at $108.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas HAE's P/E ratio is 21.71. In terms of profitability, VNRX's ROE is +0.77%, compared to HAE's ROE of +0.11%. Regarding short-term risk, VNRX is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check HAE's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas NARI's P/E ratio is -59.24. In terms of profitability, VNRX's ROE is +0.77%, compared to NARI's ROE of -0.00%. Regarding short-term risk, VNRX is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check NARI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, LIVN has a market cap of 4.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while LIVN trades at $78.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas LIVN's P/E ratio is 18.70. In terms of profitability, VNRX's ROE is +0.77%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, VNRX is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check LIVN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ITGR trades at $125.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ITGR's P/E ratio is 19.71. In terms of profitability, VNRX's ROE is +0.77%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, VNRX is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ITGR's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while IRTC trades at $128.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas IRTC's P/E ratio is -200.81. In terms of profitability, VNRX's ROE is +0.77%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, VNRX is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check IRTC's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VNRX's ROE is +0.77%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VNRX is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check AXNX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, TMDX has a market cap of 3.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while TMDX trades at $94.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas TMDX's P/E ratio is 48.06. In terms of profitability, VNRX's ROE is +0.77%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, VNRX is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check TMDX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AXGN has a market cap of 2.7B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AXGN trades at $50.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AXGN's P/E ratio is 132.63. In terms of profitability, VNRX's ROE is +0.77%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, VNRX is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for VNRX.Check AXGN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BFLY trades at $9.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BFLY's P/E ratio is -39.79. In terms of profitability, VNRX's ROE is +0.77%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, VNRX is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BFLY's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while UFPT trades at $309.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas UFPT's P/E ratio is 31.58. In terms of profitability, VNRX's ROE is +0.77%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, VNRX is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check UFPT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ESTA trades at $72.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ESTA's P/E ratio is -57.67. In terms of profitability, VNRX's ROE is +0.77%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, VNRX is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ESTA's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VNRX's ROE is +0.77%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VNRX is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check NUVA's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while NVCR trades at $17.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas NVCR's P/E ratio is -11.18. In terms of profitability, VNRX's ROE is +0.77%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, VNRX is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check NVCR's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while INSP trades at $62.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas INSP's P/E ratio is 27.51. In terms of profitability, VNRX's ROE is +0.77%, compared to INSP's ROE of +0.18%. Regarding short-term risk, VNRX is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check INSP's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CNMD trades at $51.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CNMD's P/E ratio is 11.29. In terms of profitability, VNRX's ROE is +0.77%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, VNRX is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CNMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while TNDM trades at $22.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas TNDM's P/E ratio is -24.00. In terms of profitability, VNRX's ROE is +0.77%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, VNRX is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check TNDM's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ENOV trades at $26.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ENOV's P/E ratio is 7.46. In terms of profitability, VNRX's ROE is +0.77%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, VNRX is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ENOV's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ATEC trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ATEC's P/E ratio is -158.00. In terms of profitability, VNRX's ROE is +0.77%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, VNRX is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ATEC's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AORT trades at $28.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AORT's P/E ratio is 46.82. In terms of profitability, VNRX's ROE is +0.77%, compared to AORT's ROE of -0.01%. Regarding short-term risk, VNRX is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check AORT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VNRX's ROE is +0.77%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VNRX is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check HSKA's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while IART trades at $16.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas IART's P/E ratio is 7.09. In terms of profitability, VNRX's ROE is +0.77%, compared to IART's ROE of -0.01%. Regarding short-term risk, VNRX is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check IART's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PRCT trades at $21.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PRCT's P/E ratio is -11.18. In terms of profitability, VNRX's ROE is +0.77%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, VNRX is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check PRCT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, LMRI has a market cap of 1.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while LMRI trades at $12.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas LMRI's P/E ratio is -24.16. In terms of profitability, VNRX's ROE is +0.77%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, VNRX is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check LMRI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AVNS trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AVNS's P/E ratio is 27.77. In terms of profitability, VNRX's ROE is +0.77%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, VNRX is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check AVNS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while IRMD trades at $87.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas IRMD's P/E ratio is 44.15. In terms of profitability, VNRX's ROE is +0.77%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, VNRX is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check IRMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SILK's P/E ratio is -18.96. In terms of profitability, VNRX's ROE is +0.77%, compared to SILK's ROE of -0.35%. Regarding short-term risk, VNRX is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SILK's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas FNA's P/E ratio is -19.83. In terms of profitability, VNRX's ROE is +0.77%, compared to FNA's ROE of -0.35%. Regarding short-term risk, VNRX is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check FNA's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BVS has a market cap of 974.2M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BVS trades at $14.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BVS's P/E ratio is 18.92. In terms of profitability, VNRX's ROE is +0.77%, compared to BVS's ROE of +0.28%. Regarding short-term risk, VNRX is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BVS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CBLL has a market cap of 922.4M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CBLL trades at $24.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CBLL's P/E ratio is -14.91. In terms of profitability, VNRX's ROE is +0.77%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, VNRX is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CBLL's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SIBN has a market cap of 885.2M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SIBN trades at $19.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SIBN's P/E ratio is -58.71. In terms of profitability, VNRX's ROE is +0.77%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, VNRX is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SIBN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AVR has a market cap of 873.1M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AVR trades at $8.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AVR's P/E ratio is -4.03. In terms of profitability, VNRX's ROE is +0.77%, compared to AVR's ROE of -0.78%. Regarding short-term risk, VNRX is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check AVR's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, INMD has a market cap of 865.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while INMD trades at $15.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas INMD's P/E ratio is 10.46. In terms of profitability, VNRX's ROE is +0.77%, compared to INMD's ROE of +0.12%. Regarding short-term risk, VNRX is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check INMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BBNX has a market cap of 857.1M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BBNX trades at $19.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BBNX's P/E ratio is -12.62. In terms of profitability, VNRX's ROE is +0.77%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, VNRX is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BBNX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CSII's P/E ratio is -20.83. In terms of profitability, VNRX's ROE is +0.77%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VNRX is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CSII's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, VREX has a market cap of 779.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while VREX trades at $18.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas VREX's P/E ratio is 19.48. In terms of profitability, VNRX's ROE is +0.77%, compared to VREX's ROE of +0.05%. Regarding short-term risk, VNRX is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check VREX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, AHCO has a market cap of 766M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while AHCO trades at $5.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas AHCO's P/E ratio is 11.49. In terms of profitability, VNRX's ROE is +0.77%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, VNRX is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check AHCO's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SSII has a market cap of 717.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SSII trades at $3.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SSII's P/E ratio is -69.92. In terms of profitability, VNRX's ROE is +0.77%, compared to SSII's ROE of -0.27%. Regarding short-term risk, VNRX is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SSII's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, KIDS has a market cap of 658.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while KIDS trades at $25.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas KIDS's P/E ratio is -21.74. In terms of profitability, VNRX's ROE is +0.77%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, VNRX is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check KIDS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SRDX's P/E ratio is -34.66. In terms of profitability, VNRX's ROE is +0.77%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, VNRX is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SRDX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CTKB has a market cap of 601.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CTKB trades at $4.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CTKB's P/E ratio is -24.69. In terms of profitability, VNRX's ROE is +0.77%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, VNRX is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CTKB's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, DCTH has a market cap of 591.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while DCTH trades at $17.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas DCTH's P/E ratio is 1714.00. In terms of profitability, VNRX's ROE is +0.77%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, VNRX is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check DCTH's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BWAY has a market cap of 587.2M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BWAY trades at $14.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BWAY's P/E ratio is 38.03. In terms of profitability, VNRX's ROE is +0.77%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, VNRX is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check BWAY's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas APEN's P/E ratio is -9.43. In terms of profitability, VNRX's ROE is +0.77%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VNRX is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check APEN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CERS has a market cap of 562.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CERS trades at $2.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CERS's P/E ratio is -55.69. In terms of profitability, VNRX's ROE is +0.77%, compared to CERS's ROE of -0.10%. Regarding short-term risk, VNRX is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CERS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, TCMD has a market cap of 537.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while TCMD trades at $23.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas TCMD's P/E ratio is 22.06. In terms of profitability, VNRX's ROE is +0.77%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, VNRX is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check TCMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, VNRX's ROE is +0.77%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, VNRX is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ZIMV's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, NPCE has a market cap of 478.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while NPCE trades at $14.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas NPCE's P/E ratio is -24.61. In terms of profitability, VNRX's ROE is +0.77%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, VNRX is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check NPCE's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CLPT has a market cap of 455.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CLPT trades at $15.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CLPT's P/E ratio is -12.87. In terms of profitability, VNRX's ROE is +0.77%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, VNRX is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CLPT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SGHT has a market cap of 449.4M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SGHT trades at $8.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SGHT's P/E ratio is -14.75. In terms of profitability, VNRX's ROE is +0.77%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, VNRX is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SGHT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CARL has a market cap of 448.6M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CARL trades at $16.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CARL's P/E ratio is -11.54. In terms of profitability, VNRX's ROE is +0.77%, compared to CARL's ROE of -0.38%. Regarding short-term risk, VNRX is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CARL's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PACB has a market cap of 427.1M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PACB trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PACB's P/E ratio is -3.35. In terms of profitability, VNRX's ROE is +0.77%, compared to PACB's ROE of -49.62%. Regarding short-term risk, VNRX is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for VNRX.Check PACB's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SENS has a market cap of 405.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SENS trades at $9.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SENS's P/E ratio is -4.35. In terms of profitability, VNRX's ROE is +0.77%, compared to SENS's ROE of -1.66%. Regarding short-term risk, VNRX is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SENS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, OFIX has a market cap of 404.6M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while OFIX trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas OFIX's P/E ratio is -13.08. In terms of profitability, VNRX's ROE is +0.77%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, VNRX is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check OFIX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CATX has a market cap of 367.2M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CATX trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CATX's P/E ratio is -2.42. In terms of profitability, VNRX's ROE is +0.77%, compared to CATX's ROE of -0.42%. Regarding short-term risk, VNRX is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CATX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ELMD has a market cap of 327.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ELMD trades at $39.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ELMD's P/E ratio is 33.80. In terms of profitability, VNRX's ROE is +0.77%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, VNRX is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ELMD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, TLSI has a market cap of 324.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while TLSI trades at $5.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas TLSI's P/E ratio is -3.14. In terms of profitability, VNRX's ROE is +0.77%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, VNRX is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check TLSI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas SMLR's P/E ratio is 3.92. In terms of profitability, VNRX's ROE is +0.77%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, VNRX is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check SMLR's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, CV has a market cap of 300.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while CV trades at $6.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas CV's P/E ratio is -2.41. In terms of profitability, VNRX's ROE is +0.77%, compared to CV's ROE of -1.78%. Regarding short-term risk, VNRX is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check CV's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ANIK has a market cap of 291.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ANIK trades at $21.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ANIK's P/E ratio is 44.45. In terms of profitability, VNRX's ROE is +0.77%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, VNRX is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ANIK's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, TMCI has a market cap of 281.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while TMCI trades at $4.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas TMCI's P/E ratio is -4.62. In terms of profitability, VNRX's ROE is +0.77%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, VNRX is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check TMCI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, RXST has a market cap of 258.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while RXST trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas RXST's P/E ratio is -5.53. In terms of profitability, VNRX's ROE is +0.77%, compared to RXST's ROE of -0.17%. Regarding short-term risk, VNRX is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check RXST's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, RCEL has a market cap of 249.9M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while RCEL trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas RCEL's P/E ratio is -6.99. In terms of profitability, VNRX's ROE is +0.77%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, VNRX is more volatile compared to RCEL. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check RCEL's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, PROF has a market cap of 246.7M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while PROF trades at $6.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas PROF's P/E ratio is -6.93. In terms of profitability, VNRX's ROE is +0.77%, compared to PROF's ROE of -0.56%. Regarding short-term risk, VNRX is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check PROF's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas MGRM's P/E ratio is -12.00. In terms of profitability, VNRX's ROE is +0.77%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, VNRX is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check MGRM's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VNRX's ROE is +0.77%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VNRX is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check NVRO's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, STIM has a market cap of 208.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while STIM trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas STIM's P/E ratio is -6.82. In terms of profitability, VNRX's ROE is +0.77%, compared to STIM's ROE of -1.51%. Regarding short-term risk, VNRX is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check STIM's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas BSGM's P/E ratio is -5.81. In terms of profitability, VNRX's ROE is +0.77%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, VNRX is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for VNRX.Check BSGM's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, LUCD has a market cap of 184M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while LUCD trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas LUCD's P/E ratio is -2.61. In terms of profitability, VNRX's ROE is +0.77%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, VNRX is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check LUCD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas MDGS's P/E ratio is -0.27. In terms of profitability, VNRX's ROE is +0.77%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, VNRX is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for VNRX.Check MDGS's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas QIPT's P/E ratio is -15.87. In terms of profitability, VNRX's ROE is +0.77%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, VNRX is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check QIPT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, FOCL has a market cap of 154.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while FOCL trades at $4.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas FOCL's P/E ratio is -3.99. In terms of profitability, VNRX's ROE is +0.77%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, VNRX is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check FOCL's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, INGN has a market cap of 151.9M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while INGN trades at $5.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas INGN's P/E ratio is -6.16. In terms of profitability, VNRX's ROE is +0.77%, compared to INGN's ROE of -0.13%. Regarding short-term risk, VNRX is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check INGN's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, QTRX has a market cap of 140.8M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while QTRX trades at $2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas QTRX's P/E ratio is -1.18. In terms of profitability, VNRX's ROE is +0.77%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, VNRX is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check QTRX's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, HSDT has a market cap of 122.6M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while HSDT trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas HSDT's P/E ratio is -0.02. In terms of profitability, VNRX's ROE is +0.77%, compared to HSDT's ROE of -1.23%. Regarding short-term risk, VNRX is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for VNRX.Check HSDT's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while ICAD trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas ICAD's P/E ratio is -20.37. In terms of profitability, VNRX's ROE is +0.77%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, VNRX is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check ICAD's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while HJLI trades at $10.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas HJLI's P/E ratio is N/A. In terms of profitability, VNRX's ROE is +0.77%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, VNRX is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check HJLI's competition here

VolitionRX Ltd (AMEX: VNRX) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VNRX stands at 3.4M. In comparison, LUNG has a market cap of 95.5M. Regarding current trading prices, VNRX is priced at $0.42 on the AMEX, while LUNG trades at $2.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VNRX currently has a P/E ratio of -0.11, whereas LUNG's P/E ratio is -1.95. In terms of profitability, VNRX's ROE is +0.77%, compared to LUNG's ROE of -0.97%. Regarding short-term risk, VNRX is more volatile compared to LUNG. This indicates higher risk in terms of short-term price fluctuations for VNRX.Check LUNG's competition here